You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 84 Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in advanced peritoneal carcinomatous (APC) at the american university of beirut medical center (AUBMC): a retrospective review

Article Text

Article menu

Download PDFPDF

E-Poster discussions
Poster Discussion with the Professor Station 2
IGCS19-0347
84 Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) in advanced peritoneal carcinomatous (APC) at the american university of beirut medical center (AUBMC): a retrospective review
Free
  1. M Seoud1,
  2. A El Housheimi1,
  3. A Shamseddine2,
  4. M Khalifeh3,
  5. I Jaafar1 and
  6. F Jamali3
  1. 1American University of Beirut Medical Center, Obstetrics and Gynecology, Beirut, Lebanon
  2. 2American University of Beirut Medical Center, Hematology and Oncology, Beirut, Lebanon
  3. 3American University of Beirut Medical Center, General surgery, Beirut, Lebanon

Abstract

Objectives To review the outcome of patients with APC who underwent CRS+HIPEC by the HIPEC team at the AUBMC.

Methods All patients with APC were evaluated by the HIPEC team for eligibility and the majority had either gastrointestinal or gynecological malignancies. We retrospectively reviewed data related to their demographics/tumor origin/surgical completeness/adverse events/outcome.

Results between 2007 and 2018, 53 patients (45% were females) had CRS and HIPEC. 20 (37.6%) had Pseudomyxoma peritonei (PMP), 12 (23%) ovarian cancer, 14 (26.4%) colorectal cancer, 4 (7.5%) had gastric cancer, 2 (3.7%) had Mesothelioma and one (1.8%) Desmoplastic round cell tumor. Operative and Postoperative demographics and survivals are shown in tables 1 and 2. Median progression free (PFS) and overall survival (OS) are expressed in months.

View this table:
Abstract 84 Table 1

Operative and postoperative data

View this table:
Abstract 84 Table 2

Survival data

Conclusions We report the successful establishment of an active peritoneal surface malignancy multidisciplinary treatment program with results comparable to other centers. Careful patient selection, a multidisciplinary approach and proper surgical training and technique are essential for the success of such a program.

https://doi.org/10.1136/ijgc-2019-IGCS.84

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.